Health economics is essentially an analytical discipline.  It collects, collates, measures, models, extrapolates, evaluates, compares and concludes.  But does it also tell stories?  Health economic and outcomes research arguments are increasingly being communicated in terms of value stories.  Underlying this move is the realization that many payers and decision-makers are not trained health economists and may not respond well to academically-expressed economic arguments. 

So what exactly is a value story?  Is it the same as a value dossier?   What is the role of health economists in developing value stories?  Are health economists equipped to think in terms of narrative rather than analysis?  Is a single value story suitable for use with all audiences?  Can economic models and outcomes research data be presented in narrative terms?  And what is so special about a narrative approach anyway?  In this moderated discussion, a panel of senior healthcare industry representatives will explore answers to these key questions on the role of narrative in communicating health economics and product value.

Moderator: John Fanshawe BA, Co-Principal, Medaxial Group, London, UK
Speakers: Joseph DiCesare, MPH, RPh, Vice President, Global Health Economics & Outcomes Research Novartis Pharmaceuticals Corp. East Hanover, NJ
Marko A. Mychaskiw RPh, PhD, Director Therapy Area Lead, Outcomes Research, Pfizer, New York, NY, USA
Mark P. Allyn MSc, Senior Director, Global Health Outcomes and Strategic Pricing, Genzyme, Cambridge,
MA, USA
Trevor Leighton MBA, BSc, Vice President, Pricing & Reimbursement, Shire Pharmaceuticals, Basingstoke, UK

Symposium Presentation

Register for Proceedings

This presentation will explain the Archimedes Model and its role in prioritization of interventions based on expected health outcomes. The Model can be used to perform a wide variety of sensitivity analyses to understand the expected health outcomes of a set of interventions, providing information for critical decisions during the drug development process.